Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

3.4.24.83: anthrax lethal factor endopeptidase

This is an abbreviated version!
For detailed information about anthrax lethal factor endopeptidase, go to the full flat file.

Word Map on EC 3.4.24.83

Reaction

Preferred amino acids around the cleavage site can be denoted BBBBxHx-/-H, in which B denotes Arg or Lys, H denotes a hydrophobic amino acid, and x is any amino acid. The only known protein substrates are mitogen-activated protein (MAP) kinase kinases =

Synonyms

anthrax lethal factor, anthrax lethal factor protease, anthrax lethal toxin, anthrax LF, anthrax toxin lethal factor, Bacillus anthracis lethal toxin, lethal factor, lethal factor of anthrax toxin, lethal toxin, LeTx, LF, LTx

ECTree

     3 Hydrolases
         3.4 Acting on peptide bonds (peptidases)
             3.4.24 Metalloendopeptidases
                3.4.24.83 anthrax lethal factor endopeptidase

Engineering

Engineering on EC 3.4.24.83 - anthrax lethal factor endopeptidase

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
E269A
the mutant shows strongly increased cleavage ability for mitogen-activated protein kinase kinase-1 and reduced activity with mitogen-activated protein kinase kinase-6 compared to the wild type enzyme
E539R
the mutant shows slightly increased cleavage ability for mitogen-activated protein kinase kinase-1 and reduced activity with mitogen-activated protein kinase kinase-6 compared to the wild type enzyme
E678A
-
mutant fails to induce cell death
E678C
-
catalytically inactive
E687C
-
inactive
E687D
-
mutation in metal-binding site, decrease in catalytic activity
E720C
-
catalytic mutant
H686A
-
inactive
H690A
K518E/E682G
-
mutation in anthrax lethal factor, mutant is defective at causing pyroptosis in RAW 264.7 cells and at activating the Nlrp1b inflammasome in a heterologous expression system. LF-K518E /E682G does not exhibit an overall impairment of function and LF-K518E /E682G efficiently kills melanoma cells
K75A
the mutant shows wild type activity
L259A
the mutant cleaves MEK1 about 2fold less efficiently than the wild type enzyme
L265A
the mutation does not significantly impact on MEK1 cleavage
L431A
the mutant shows slightly increased cleavage ability for mitogen-activated protein kinase kinase-6 compared to the wild type enzyme
M264A
the mutant cleaves MEK1 2.5fold less efficiently than the wild type enzyme
R263A
the mutant shows reduced cleavage ability for mitogen-activated protein kinase kinase-1 compared to the wild type enzyme
R491E
the mutant cleaves MEK1 about 2fold less efficiently than the wild type enzyme
W271A
the mutation completely abolishes cleavage ability of mitogen-activated protein kinase kinase-6 but has no effect on the ability to cleave MEK1. The mutant blocks ERK phosphorylation and growth in a melanoma cell line, suggesting that it may provide a highly selective inhibitor of MEK1/2 for use as a cancer therapeutic
Y268A
the mutant cleaves MEK1 6fold less efficiently than the wild type enzyme
additional information